U.S. Physical Therapy (USPH) Earnings Analysis
U.S. Physical Therapy (USPH) has no confirmed upcoming earnings date. Last quarter (2026-02-25) it beat with EPS 0.67 USD vs 0.67 USD est (0%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 148.76.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does USPH next report earnings?
No confirmed upcoming earnings date is currently scheduled for USPH. This page updates as the calendar is published.
USPH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | 0.67 USD | 0.67 USD | 0% | Beat |
| 2025-02-26 | 0.65 USD | 0.69 USD | -5.8% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
USPH valuation and analyst view
| Trailing P/E | 148.76 |
|---|---|
| Trailing EPS | 0.0778 USD |
| Price / book | 2.41 |
| Dividend yield | 2.45% |
| Market cap | 1.12B |
| Analyst consensus | Buy (10 buy / 3 hold / 0 sell) |
| Avg price target | 90 USD |
Related research pages
Frequently asked questions
When is U.S. Physical Therapy (USPH)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for USPH. This page updates as the calendar is published.
Did USPH beat earnings last quarter?
In its 2026-02-25 report, USPH posted EPS of 0.67 USD versus a 0.67 USD estimate — a beat of 0%.
What is USPH's earnings track record?
Over the last 2 reported quarters with consensus data, USPH beat estimates 1 times (50%).
What is USPH's current P/E ratio and EPS?
USPH trades at a trailing P/E of 148.76 on trailing EPS of 0.0778004879013648 USD.
What do analysts rate USPH?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 90 USD.